A Bayesian Critique of Rank-Based Methods for Surrogate Marker Evaluation

2026-03-15

AI Summary

Existing rank-based surrogate marker evaluation methods suffer from a lack of causal interpretability, low statistical power, and sensitivity to the underlying data-generating mechanism. This work proposes a novel approach that integrates causal inference with Bayesian modeling to directly estimate causal treatment effects while incorporating covariate adjustment, thereby enhancing both accuracy and efficiency in surrogate assessment. By explicitly modeling the causal relationship between treatment, surrogate, and outcome, the method overcomes the limitations of traditional nonparametric ranking procedures in terms of interpretability and statistical power. Extensive simulation studies demonstrate that the proposed method consistently outperforms existing approaches across a range of data-generating scenarios, exhibiting superior robustness and precision.

Technology Category

• Machine Learning: Learning Preferences or Rankings
• Reasoning under Uncertainty: Causality
• Search and Optimization: Sampling/Simulation-based Search

Application Category

• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking
• User Modeling, Personalization and Recommendation: Fairness-aware retrieval and ranking
• Graph Algorithms and Modeling for the Web: Representation, reconstruction, and subgraph or motif discovery in Web-related graphs

Abstract

Surrogate markers are often employed in clinical trials to replace primary outcomes that may be difficult, expensive, or time-consuming to measure directly. These markers can accelerate the evaluation of new treatments, provided they reliably capture the causal relationship between treatment and true clinical benefit. Parast et al. (2024) recently proposed a rank-based approach for evaluating surrogate markers, characterized by its nonparametric nature and minimal assumptions. While this method is useful in small-sample model-agnostic settings, it has several limitations, including a lack of clear causal interpretation, low statistical power, and insufficient robustness to different data-generating mechanisms. In this paper, we propose a Bayesian approach that addresses these shortcomings by focusing on causal treatment effect estimands and, in doing so, improves power through covariate adjustment. We demonstrate the advantages of our proposed method through a simulation study designed to highlight gains in both accuracy and power.

Problem

• surrogate marker
• rank-based methods
• causal interpretation
• statistical power
• robustness

Innovation

• Bayesian approach
• surrogate marker evaluation
• causal treatment effect
• covariate adjustment
• statistical power